Zhejiang East Asia Pharmaceutical Co., Ltd. Class ASSE: 605177

Announcement on 2026 Interest Payment of "East-Asia Convertible Bonds"

Jun 30, 2026 · Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on 2026 Interest Payment of "East-Asia Convertible Bonds"

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Zhejiang East Asia Pharmaceutical Co., Ltd. Class A

Announcement on SSE’s Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual ReportJun 24
Announcement on 2026 Follow-up Rating Results of Convertible Corporate Bonds Issued to Non-specific ObjectsJun 19
Announcement on Completing Industrial and Commercial Change Registration of Business Scope and Obtaining Renewed Business LicenseMay 20

All Zhejiang East Asia Pharmaceutical Co., Ltd. Class A news releases